Skip to main content

Artificial Intelligence

By HIMSS TV | 11:23 am | April 14, 2023
Academia is working to decrease bias in AI and to guard against potential pitfalls of its use in patient care, says Ty Vachon, CEO and cofounder of Oatmeal Health in a preview of his HIMSS23 discussion.
By HIMSS TV | 02:56 pm | April 13, 2023
Danielle Pieloch and Kumar Aditya, who will be speaking at HIMSS23, discuss how a "schedule first, then authorize approach" triggers an automated prior authorization workflow that reduces wait times for radiology services at Atlantic Health System.
By Andrea Fox | 11:42 am | April 13, 2023
Their collaboration to develop new cloud-based artificial intelligence for healthcare will focus on improved care and delivery outcomes, business operations and health services research.
By HIMSS TV | 07:00 am | April 13, 2023
The Transcarent CEO, speaking ahead of his upcoming HIMSS23 presentation with HIMSS CEO Hal Wolf, says virtual care and AI will help move healthcare into an era of consumerization.
By Andrea Fox | 12:43 pm | April 12, 2023
The National Council for Prescription Drug Programs chose the company for its prescriber database because of "its national coverage, profile depth, flexibility and integrity," the council's president and CEO said.
By Mike Miliard | 11:54 am | April 12, 2023
With quantum computing now a reality, and poised to turbocharge machine learning and precision medicine across healthcare, one expert who's speaking at HIMSS23 says it's time to prepare.
By Bill Siwicki | 11:18 am | April 12, 2023
"Continuous distribution" is a framework designed to make organ transplants more equitable. Experts from MIT and UNOS explain how it works.
By Andrea Fox | 04:15 pm | April 11, 2023
The agency hopes the NPRM provisions will further move the needle on interoperability, expanding "appropriate access, exchange and use of electronic health information" with an eye toward health equity, said the National Coordinator for Health IT.
By Andrea Fox | 11:03 am | April 11, 2023
The partners will use natural language processing technology and de-identified EHR data better to help the agency research how medications affect large populations.